Geographic Expansion Khiron operates across Latin America and Europe with sales in Colombia, Peru, Germany, UK, and Brazil and plans to commence sales in Mexico, indicating multiple growth entry points and potential channel partnerships, distributors, and clinic collaborations in new markets.

Integrated Model Vertical integration combining medical clinics, telemedicine, and agricultural infrastructure suggests opportunities to bundle products with patient services, cross-sell therapy programs, and leverage data-driven physician education to drive increased prescriptions.

Healthcare Partnerships Existing alliance with clinics and telemedicine platforms presents a pathway to partner with regional health systems, private clinics, and occupational health programs to scale clinician-led adoption and patient access for medical cannabis therapies.

European Distribution EU-GMP distribution hub in Germany enables reach to Germany, UK, and Switzerland; potential to pursue wholesale, white-label, and regulatory-compliant product partnerships targeting European healthcare providers and pharmacies.

Growth Financing Recent financing activity and leadership changes imply a phase of capital-efficient expansion; sales opportunities can align with customers open to pilot programs, clinics under development, and region-specific funding support for program adoption and education.